Cubist Pharmaceuticals Inc news

   Watch this stock
Showing stories 1 - 10 of about 98   

Articles published

CBST 65.60 -0.95 (-1.43%)
price chart
Market Movers : Cubist Pharmaceuticals Inc. (NASDAQ:CBST), Honeywell ...
Shares of Cubist Pharmaceuticals Inc. (NASDAQ:CBST) have received a consensus recommendation of �Buy� from the fourteen ratings firms that are presently covering the stock, AnalystRatings.
Cubist Pharmaceuticals' Antibiotic Accepted for EU Review - Analyst Blog
The European Medicines Agency (EMA) accepted Cubist Pharmaceuticals, Inc .'s ( CBST ) Marketing Authorization Application (MAA) for its investigational antibiotic, ceftolozane/tazobactam.
Cubist to Present New Data from Antibiotics Portfolio at 54th Interscience ...  Business Wire (press release)
Related articles »  
Morning Buzz : Goldcorp Inc. (NYSE:GG), Cubist Pharmaceuticals Inc. (NASDAQ ...
On AUG 26, Cubist Pharmaceuticals, Inc. (NASDAQ:CBST) announced that it will present new data at the 54thInterscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), September 5-9 in Washington, D.C.
Pharma Stock News: Synergy Pharmaceuticals Inc (NASDAQ:SGYP), Cubist ...
Synergy Pharmaceuticals Inc (NASDAQ:SGYP) Thursday said that it has reached the halfway mark in a phase 3 trial of its drug plecanatide, for treatment of patients with chronic idiopathic constipation, or constipation without identifiable medical or ...
Cubist Pharmaceuticals Larger Than S&P 500 Component PerkinElmer
In the latest look at stocks ordered by largest market capitalization, Russell 3000 component Cubist Pharmaceuticals Inc. (Symbol: CBST) was identified as having a larger market cap than the smaller end of the S&P 500, for example PerkinElmer, Inc.
Related articles »  
Cubist Pharmaceuticals Given Average Recommendation of "Buy" by ...
Cubist Pharmaceuticals logo Shares of Cubist Pharmaceuticals (NASDAQ:CBST) have received a consensus recommendation of �Buy� from the fourteen analysts that are covering the company, ARN reports. One investment analyst has rated the stock with a ...
Cubist Pharmaceuticals SVP Gregory Stea Unloads 38326 Shares (CBST)
Cubist Pharmaceuticals logo Cubist Pharmaceuticals (NASDAQ:CBST) SVP Gregory Stea unloaded 38,326 shares of the company's stock on the open market in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $65.88, ...
Top Wall Street Stories : Nokia Corporation (ADR) (NYSE:NOK), Teva ...
On September 18, Cubist Pharmaceuticals Inc. (NASDAQ:CBST), a Lexington company specializing in antibiotics that treat resistant bacterial infections, announced Thursday the official opening of its international headquarters in Zurich.
Cubist Pharmaceuticals Receives Consensus Rating of "Buy" from Analysts ...
Cubist Pharmaceuticals has a one year low of $58.50 and a one year high of $82.12. The stock has a 50-day moving average of $64.35 and a 200-day moving average of $68.97.
Related articles »  
Morningstar Gives BBB- Credit Rating to Cubist Pharmaceuticals (CBST)
Cubist Pharmaceuticals logo Cubist Pharmaceuticals (NASDAQ:CBST) has been given a �BBB-� credit rating by analysts at Morningstar.
Stocks To Watch: Microsoft Corporation (NASDAQ:MSFT), MeetMe (NASDAQ ...  WallStreet Scope
Related articles »